|
|
||||||||||
|
J Am Coll Cardiol, 2005; 45:969-981, doi:10.1016/j.jacc.2004.11.066 © 2005 by the American College of Cardiology Foundation |
Division of Cardiology, Department of Medicine, Oregon Health and Science University, Portland, Oregon
Manuscript received July 2, 2004; revised manuscript received September 16, 2004, accepted November 22, 2004.
* Reprint requests and correspondence: Dr. Ray E. Hershberger, Division of Cardiology, UHN-62, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239 (Email: hershber{at}ohsu.edu). (URL: www.fdc.to).
Idiopathic dilated cardiomyopathy (IDC) is characterized by left ventricular dilatation and systolic dysfunction after known causes have been excluded. Idiopathic dilated cardiomyopathy occurring in families, or familial dilated cardiomyopathy (FDC), may occur in 20% to 50% of IDC cases. Sixteen genes have been shown to cause autosomal dominant FDC, but collectively may account for only a fraction of genetic causation; it is anticipated that additional genes causative of FDC will be discovered. Familial dilated cardiomyopathy demonstrates incomplete penetrance, variable expression, and significant locus and allelic heterogeneity, making clinical and genetic diagnosis complex. Echocardiographic and electrocardiographic screening of first-degree relatives of individuals with IDC and FDC is indicated, as detection and treatment are possible before the onset of advanced symptomatic disease. Genetic counseling for IDC and FDC is also indicated to assist with family evaluations for genetic disease and with the uncertainty and anxiety surrounding the significance of clinical and genetic evaluation. Genetic testing is not yet commonly available, but its emergence will provide new opportunities for presymptomatic diagnosis.
| ||||||||||||
This article has been cited by other articles:
![]() |
M. Jerosch-Herold, D. C. Sheridan, J. D. Kushner, D. Nauman, D. Burgess, D. Dutton, R. Alharethi, D. Li, and R. E. Hershberger Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1234 - H1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lombardi, A. Bell, V. Senthil, J. Sidhu, M. Noseda, R. Roberts, and A. J. Marian Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies Cardiovasc Res, July 1, 2008; 79(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Braunwald The Management of Heart Failure: The Past, the Present, and the Future Circ Heart Fail, May 1, 2008; 1(1): 58 - 62. [Full Text] [PDF] |
||||
![]() |
P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, P. Charron, O. Dubourg, U. Kuhl, B. Maisch, W. J. McKenna, et al. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases Eur. Heart J., January 2, 2008; 29(2): 270 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Wiersma, P. Stabej, P. A. J. Leegwater, B. A. Van Oost, W. E. Ollier, and J. Dukes-McEwan Evaluation of 15 Candidate Genes for Dilated Cardiomyopathy in the Newfoundland Dog J. Hered., January 1, 2008; 99(1): 73 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text] |
||||
![]() |
N. H. Robin, P. B. Tabereaux, R. Benza, and B. R. Korf Genetic Testing in Cardiovascular Disease J. Am. Coll. Cardiol., August 21, 2007; 50(8): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ashrafian and H. Watkins Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R.G. Taylor, D. Slavov, L. Ku, A. Di Lenarda, G. Sinagra, E. Carniel, K. Haubold, M. M. Boucek, D. Ferguson, S. L. Graw, et al. Prevalence of Desmin Mutations in Dilated Cardiomyopathy Circulation, March 13, 2007; 115(10): 1244 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Donahue, D. A. Marchuk, and H. A. Rockman Redefining Heart Failure: The Utility of Genomics J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1289 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Charron Clinical genetics in cardiology. Heart, August 1, 2006; 92(8): 1172 - 1176. [Full Text] [PDF] |
||||
![]() |
L. Song, S. R. DePalma, M. Kharlap, A. G. Zenovich, A. Cirino, R. Mitchell, B. McDonough, B. J. Maron, C. E. Seidman, J.G. Seidman, et al. Novel Locus for an Inherited Cardiomyopathy Maps to Chromosome 7 Circulation, May 9, 2006; 113(18): 2186 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Peddy, L. A. Vricella, J. E. Crosson, G. L. Oswald, R. D. Cohn, D. E. Cameron, D. Valle, and B. L. Loeys Infantile Restrictive Cardiomyopathy Resulting From a Mutation in the Cardiac Troponin T Gene Pediatrics, May 1, 2006; 117(5): 1830 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, J. A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A. J. Moss, C. E. Seidman, and J. B. Young Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation, April 11, 2006; 113(14): 1807 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Hershberger Reply J. Am. Coll. Cardiol., February 7, 2006; 47(3): 690 - 690. [Full Text] [PDF] |
||||
![]() |
W. Poller, H.-P. Schultheiss, and U. Kuhl Viruses and Other Environmental Factors as Possible Sources of Phenotypic Heterogeneity in Familial Dilated Cardiomyopathy J. Am. Coll. Cardiol., February 7, 2006; 47(3): 689 - 690. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |